EPIX - ESSA Pharma to Present at Upcoming September Investor Conferences

PR Newswire

VANCOUVER, Canada and HOUSTON, Texas , Aug. 31, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that David R. Parkinson , President and Chief Executive Officer of ESSA Pharma, will be presenting and hosting one-on-one meetings with investors at two upcoming virtual investor conferences. Peter Virsik , ESSA's Chief Operating Officer, and David S. Wood , ESSA's Chief Financial Officer, will also be available for one-on-one meetings.

Presentation Details

Event: H.C. Wainwright Annual Global Investment Conference
Date: Monday, September 13, 2021
Time (on-demand): 7:00 a.m. ET

Event : Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date: Tuesday, September 21, 2021
Time: 9: 05 a.m. ET

Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com . Following the events, the webcasts will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma .

SOURCE ESSA Pharma Inc